Concepedia

Ekaterina S. Shatalova

ES

9

Publications

649

Citations

9

H-Index

2018

Active since

Affiliations

Cedars-Sinai Medical Center(Current)

University of Regensburg

Terasaki Foundation

California NanoSystems Institute

University of California, Irvine

Ekaterina S. Shatalova is an author at Cedars-Sinai Medical Center specializing in medicine, nanotherapeutics, and drug delivery systems.

ORCID

Top concepts

Publications per year

2018–2023

9

Publications

9

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Anna Galstyan, Janet L. Markman, Ekaterina S. Shatalova et al. · Nature Communications · 2019 · 280 citations · Full text

A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood–Brain Barrier

Liron L. Israel, Oliver Braubach, Anna Galstyan et al. · ACS Nano · 2019 · 84 citations · Full text

, , +20

Blockade of a Laminin-411–Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

Tao Sun, Rameshwar Patil, Anna Galstyan et al. · Cancer Research · 2019 · 77 citations

Coarse particulate matter (PM2.5–10) in Los Angeles Basin air induces expression of inflammation and cancer biomarkers in rat brains

Julia Y. Ljubimova, Oliver Braubach, Rameshwar Patil et al. · Scientific Reports · 2018 · 72 citations · Full text

Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme

Rameshwar Patil, Anna Galstyan, Tao Sun et al. · Biomaterials · 2019 · 45 citations · Full text

Rows per page

1–5 of 9